Skip to content
Bold Lucky Platform

Social Media Influencers Fueling Unofficial Market for Unapproved Slimming Medication

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Removal

According to TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After moments of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages display dark colored packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.

The writer

Michelle Castro

A tech enthusiast and writer passionate about exploring innovative solutions and sharing actionable insights.

Bold Lucky Platform

Type to search articles.